Abstract: An organic light emitting display device and driving method of the same is provided. The device includes a pixel unit including pixels for receiving scan signals and emission control signals from a scan driver, and a plurality of data signals from a data driver. The device also includes a frame memory for storing input data by a frame period and transmitting the stored input data to the data driver unit. The device also includes a luminance control unit for determining the luminance of the organic light emitting display device corresponding to a total sum of the stored input data in the frame memory. The luminance control unit is adapted to: divide the input data into a plurality of regions; store the input data input into each region; and add together the input data stored in each region to calculate a total sum of the input data.

Abstract: Disclosed is an organic light emitting display that reduces the number of output lines and adjusts a white balance. A scan driver supplies scan signals to a plurality of scan lines. A data driver supplies data signals to a plurality of output lines. Demultiplexers are installed at the respective output lines, and supply the data signals to the plurality of data lines. Data capacitors are coupled with the data lines, and charge a voltage corresponding to the data signals. An image display device is coupled with the scan lines and the data lines, and includes red pixels having a red organic light emitting diode, green pixels having a green organic light emitting diode, and blue pixels having a blue organic light emitting diode. A first initialization power supply supplies a first voltage to the red pixels. A second initialization power supply supplies a second voltage to the green pixels. A third initialization power supply supplies a third voltage to the blue pixels.

Abstract: A topotecan liposomal composition which can be reconstituted from a lyophilized form to an injectable liposome suspension having selected liposome sizes in the size range between 0.05 and 0.25 microns, and between about 85-100% liposome-entrapped topotecan is disclosed.

Abstract: The present invention also relates to carvedilol free base, salts, anhydrous forms, or solvates thereof, corresponding pharmaceutical compositions or controlled release formulations, and methods delivery of carvedilol forms to the lower gastrointestingal tract or methods to treat cardiovascular diseases, which may include, but are not limited to hypertension, congestive heart failure, and angina. The present invention relates to control release formulations, which comprise various cavedilol forms, which may include, but are not limited to carvedilol free base and corresponding carvedilol salts, anhydrous forms or solvates thereof.

Abstract: An organic light emitting display that reduces the number of output lines from a data driver, attains image stability, and adjusts white balance. A plurality of demultiplexers at the primary output lines of the data driver simultaneously supply the data signals from each primary output line to a plurality of secondary output lines allowing a reduced number of primary output lines. A plurality of parasitic capacitors are formed where data lines are coupled with the pixels and are charged to a voltage corresponding to the data signal that is simultaneously provided to the pixels allowing an image of uniform brightness to be displayed. The scan period and the data period are not overlapping allowing a stable image. Capacitance values of data capacitors are set taking into consideration the light emitting efficiency of organic light emitting diodes, allowing an image of adjusted white balance.

Abstract: An organic light emitting display including a demultiplexer on each data line that splits and supplies each data signal to a plurality of data lines, thereby decreasing the number of output lines required and reducing production cost. Further, voltages corresponding to the data signals are sequentially charged in data capacitors, while the charged voltages are supplied to the pixels simultaneously allowing the organic light emitting display to display an image with uniform brightness. Scan periods for supplying the scan signals do not overlap with data periods for supplying the data signals thus yielding a stable image. Also, the capacitance of the data capacitor is set to compensate the voltage drop in the first power source line, thereby displaying an image with uniform brightness.

Abstract: A light emitting display including: a plurality of scan lines adapted to transmit scan signals; a plurality of data lines adapted to transmit a data signal; a plurality of emission control lines adapted to transmit an emission control signal; and a plurality of pixels adapted to emit light in response to the scan signal, the data signal and the emission control signal. At least two pixels receiving the scan signals through different scan lines are connected to one emission control line. With this configuration, a scan driver and a light emitting display including the same have a decreased number of wiring lines provided in a pixel portion, thereby enhancing an aperture ratio, decreasing the number of emission control signals, decreasing the number of components and wiring lines needed for the scan driver, simplifying a fabrication process, and reducing the power consumption of the light emitting display.

Abstract: This invention relates to carvedilol pharmasolve solvate, compositions containing this compound and methods of using carvedilol pharmasolve solvate to treat hypertension, congestive heart failure and angina.

Abstract: An organic light emitting display and a driving method thereof, with an improved aperture ratio is disclosed. In one embodiment, the organic light emitting display comprises: a plurality of scan lines and a plurality of emission control lines, which are arranged in a horizontal direction; a plurality of data lines arranged in a vertical direction; and a pixel portion comprising a plurality of pixel circuits electrically connected to the scan line, the emission control line and the data line, wherein each pixel circuit is connected to two organic light emitting diodes placed on different two horizontal lines, and two emission control lines are connected to the organic light emitting diodes placed on two horizontal lines in a zigzag pattern.

Abstract: A video signal processing method and a delta-structured display device using the same where video signals are rearranged in a logical structure such as a programmable logic chip. The video signal processing method includes receiving sequentially first line video signals and second line video signals, each having a plurality of video signals having red sub video signals, green sub video signals, and blue sub video signals, extracting alternately one of the red sub video signals, the green sub video signals, and the blue sub video signals for at least two successive video signals of the first line video signals and storing the extracted signals into a memory as the first line delta video signal, and alternately extracting one of the red sub video signals, the green sub video signals, and the blue sub video signals for at least two successive video signals of the second line video signals and storing the extracted signals into a memory as the first line delta video signals.

Abstract: A low-power, high-performance inverter circuit comprises first and second inverter circuit portions. The first portion comprises a first inverter, including a first pull-up element and a first pull-down element, for inverting an input signal, a first switching element connected between the first pull-down element and ground for switching the first inverter, and a first diode connected between the first pull-down element and ground in parallel with the first switching element. The second portion comprises a second inverter, including a second pull-up element and a second pull-down element, for inverting an input signal, a second switching element connected between the second pull-up element and a supply voltage terminal for switching the second inverter, and a second diode connected between the second pull-up element and the supply voltage terminal in parallel with the second switching element. An output of the first portion is connected to an input of the second portion.

Abstract: The present invention relates to a salt of carvedilol and/or corresponding solvates thereof, compositions containing such carvedilol and/or corresponding solvates thereof, and/or methods of using the aforementioned compound(s) in the treatment of certain disease states in mammals, in particular man. The present invention further relates to carvedilol phosphate salts, and/or solvates thereof, which include a novel crystalline form of carvedilol dihydrogen phosphate (i.e., which is the dihydrogen phosphate salt of 1-(carbazol-4-yloxy-3-[[2-(o-methoxyphenoxy) ethyl]amino]-2-propanol) and/or carvedilol hydrogen phosphate, etc.) and/or other corresponding solvates thereof, compositions containing these carvedilol phosphate salts and/or solvates, and methods of using the aforementioned salts and/or solvates to treat hypertension, congestive heart failure and angina, etc.

Abstract: This invention relates to pharmaceutical formulations of carvedilol in which a solubilising agent is used to solubilise carvedilol in oils and/or lipids, and methods of of using these formulations to treat hypertension, congestive heart failure and angina.

Abstract: The present invention relates to carvedilol phosphate salts, which include novel crystalline forms of carvedilol dihydrogen phosphate (i.e., dihydrogen phosphate salt of 1-(carbazol-4-yloxy-3-[[2-(o-methoxyphenoxy)ethyl]amino]-2-propanol) and/or carvedilol hydrogen phosphate, etc.), and/or solvates thereof, compositions containing the aforementioned salts and/or solvates, and methods of using the aforementioned salts and/or solvates to treat hypertension, congestive heart failure and angina, etc.

Abstract: The present invention also relates to carvedilol free base, salts, anhydrous forms, or solvates thereof, corresponding pharmaceutical compositions or controlled release formulations, and methods delivery of carvedilol forms to the lower gastrointestingal tract or methods to treat cardiovascular diseases, which may include, but are not limited to hypertension, congestive heart failure, and angina. The present invention relates to control release formulations, which comprise various cavedilol forms, which may include, but are not limited to carvedilol free base and corresponding carvedilol salts, anhydrous forms or solvates thereof.

Abstract: This invention relates to carvedilol monocitrate monohydrate, compositions containing this salt of carvedilol and methods of using this compound to treat hypertension, congestive heart failure and angina.

Abstract: Electrostatic discharge (ESD) protection circuits include first and second pads on an integrated circuit and first and second well regions in the integrated circuit substrate. The first and second well regions include respective first and second circumferences or walls. First and second diodes are included in the respective first and second well regions. The first and second diodes are serially connected between the first and second pads. A first guard ring is included adjacent the first circumference, and preferably in the first well. The first diode is included within the first guard ring. A second guard ring is also preferably included adjacent the second circumference, and most preferably in the second well. The second diode is included within the second guard ring.